Ipilimumab, a human monoclonal antibody for treatment of unresectable or metastatic melanoma.
Gail M
GM
Wilkes
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D000074324:Ipilimumab; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology / Q000556:secondary*; D009859:Oncology Nursing / Q000379:methods*; D010353:Patient Education as Topic; D017410:Practice Guidelines as Topic; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000276:immunology
D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D000074324:Ipilimumab